-
Published 3/10/2026
Carrion MN, Kienle RM, Bourque D, Drainoni ML, Hochberg NS, Dauphinais M, Mello T, Stigler Granados PE, Hamer DH. Barriers to Chagas Disease Screening among Primary Care Providers in the United States. Am J Trop Med Hyg. 2026 May 06; 114(5):857-864. PMID: 41806373.
-
Published 1/30/2026
Tabackman A, Acuña-Villaorduña C, Canning M, Karoly M, Dauphinais MR, Michaud R, Bouton TC, Bourque DL, Reifler KA, Sabharwal V, Traber K, Gupte AN, Jacobson KR, Sinha P. Low TB1 and TB2 antigen-nil is associated with increased QuantiFERON Gold Plus reversions. Int J Tuberc Lung Dis. 2026 Jan 30; 30(2):88-89. PMID: 41618115.
-
Published 8/29/2025
Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Rifampin versus isoniazid completion rates for TB infection. Int J Tuberc Lung Dis. 2025 Aug 29; 29(9):425-427. PMID: 40883884.
-
Published 7/7/2025
Reifler K, Wheelock A, Hall SM, Dauphinais M, Roytburd S, Maiullari M, Salazar A, Maldonado A, West HM, Köhler JR, Barnett ED, Gopal DM, Hamer DH, Bourque DL. Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion. PLoS Negl Trop Dis. 2025 Jul; 19(7):e0013218. PMID: 40622934.
-
Published 12/17/2024
Reifler K, Campbell JI, Barnett ED, Bourque DL, Hamer DH, Samra H, Camelo I. Diagnosing Chagas in Pregnancy and Childhood: What's Old and New. Clin Lab Med. 2025 Mar; 45(1):73-86. PMID: 39892939.